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dromes. Although the patient may represent a forme
fruste of such an inherited disorder, it appears that the
immune disorder described is more likely to be the result
of an acquired intra-uterine infection. We have advised
against amniocentesis and interference with the present
pregnancy. Follow-up studies may permit an aetiological
diagnosis to be established, since immune deficiency states
associated with congenital infections usually improve with
time.
We w}sh to thank the staff of the Virology Department of
the Pohomyelitis Research Foundation for performing the
antibody titres; Dr E. Wilton, for the buccal smear and
chromosome analyses; Dr J. J. Rippey, for reviewing the
lymph node biopsy; and Miss G. Rogers for technical assist-
ance. Due acknowledgement is made to the Atomic Energy
Board and the South African Medical Research Council for
assistance and support.
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Estimating Lecithin/Sphingomyelin Area Ratio
in Amniotic Fluid




A knowledge of the pulmonary maturity of the unborn
fetus is an important factor in deciding when to induce
birth. A lecithin/sphingomyelin area ratio is obtained by
thin-layer chromatography. A molybdenum spray is used
to make visible only the choline-containing phospholipids,
without necessitating the use of heat. This is a quick and
easy method which produces reliable results.
S. A fr. Med. l., 48, 690 (1974).
The respiratory distress syndrome is a major cause of
death in premature infants. Thus, a knowledge of the
pulmonary maturity of the fetus would be a great
Department of Physiology, University of Natal, Durban
DIANA G. RICHARDSO .
Date received: 24 September 1973.
asset in selecting the optimum time for induction of
labour. Until recently, fetal lung maturity was very
difficult, if not impossible, to predict. However, in 1971
Gluck et al.' successfully predicted the onset of neonatal
respiratory distress by measuring the relative Clmcentra-
tions of the phospholipids lecithin and sphingomyelin in
amniotic fluid. These phospholipids originate prim.lpaIIy
from the fetal lung, and since the lung secretions reach
the amniotic fluid,'" the increased accumulation of lecithlO
in the alveoli from about the 35th week of gestation i~
reflected in a sharply rising concentration of lecithin in
the amniotic fluid.' As this terminal increase is not matched
by a parallel increase in sphingomyelin, the latter can be
used as a baseline and the ratio between these two
surface-active phospholipids in the amniotic fluid calculated.
This ratio provides a sensitive index of fetal lung
maturity and of the likelihood of neonatal respiratory
distress if delivery is induced.'" Prior to 35 weeks of
gestation the concentrations of lecithin and sphingomyelin
are similar.
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lecithin
sphingomyelin
. which results in its separation into two phases. The upper
phase, which is the aqueous phase, is carefully removed
and discarded, while the lower chloroform phase containing
the phospholipids is filtered through Whatman No. 4
paper. The filtrate is heated to 80° - 85°C to evaporate off
the chloroform, and the resulting dry lipid residue is then
dissolved in 5 drops of chloroform (delivered with a 2-ml
graduated pipette).
With the help of a spotting guide the sample is applied
to the silica gel plate as a 5-Jllitre spot at a point 2 cm
from the base of the plate. Care must be taken to ensure
that the application site is less than 3 mm in diameter.
This can be achieved by applying a small volume of the
sample at a time, and drying between each application
with a warm-air dryer.
A 20 X 20 cm sheet of filter paper is then placed
adjacent to each of the two faces of the chromatography
tank, after which the solvent is poured into the tank and
the filter paper moistened by gently tipping the tank to
one side and then the other. The silica gel plate is then
placed in the tank and allowed to stand until the
solvent front has risen 12 cm above the application site
of the amniotic fluid. This takes approximately 45 min.
After the run, the plate is dried with a warm-air dryer.
The phospholipids are then rendered visible by spraying
the plate gently with the molybdenum spray reagent, at
a distance of about 20 cm, until the lecithin and sphingo-
myelin spots become visible. This spray causes the choline-
containing phospholipids, lecithin and sphingomyelin, to
become visible, and they appear as blue spots against a
white background. The lecithin appears as the upper of
the two spots, and is generally larger in area and more
intense than the lower sphingomyelin spot (Fig. 1). The
areas of the lecithin and sphingomyelin spots are then
measured by multiplying length by width (see Appendix)
and the ratio:
Lecithin is the major component of surfactant, the
surface-active layer which lines the alveoli, imparting
stability to the alveolus by lowering the surface tension of
its aqueous lining to almost zero.... When expiration
occurs without the presence of this surface activity the
pressure difference, as shown by (A), on the alveolus
increases considerably, due to the high surface tension of
the water-based alveolar lining and the decreasing radius
of the alveolus:
2T
Pi Pe = -- ... (A)
r
Pi internal pressure
Pe = external pressure
T = surface tension
r = radius of alveolus
This causes alveolar collapse which is characteristic of
the respiratory distress syndrome in which normal surface
activity and thus alveolar stability are absent, leading to
progressive atelectasis and hyaline membrane disease,
sometimes resulting in death.
MATERIALS AND METHODS
Reagents
Developing solvent consists of chloroform : methanol :
water: : 75 : 22 : 3 (v/v).
Silica gel plates: 30 g silica gel H (Merck, catalogue No.
7736) and 10 g silica gel G (Merck, catalogue No. 7731)
are slurried in 90 ml water for 1t min and the resulting
mixture spread on 20 X 20 cm or 10 X 20 cm glass plates
to a thickness of 250 Jlm. These quantities are sufficient
for five 20 X 20 cm plates. When dry, the plates are
activated at 110°C for 1 hour, and stored in a desiccator
until needed.
Standards: Purified lecithin (dipalrnitoyl) and sphingo-
myelin, purchased from General Biochernicals, were used
for making up the two standards in the concentration of
5 mg/ml of chloroform. These standards are stable for
several months when stored in a refrigerator.
Molybdenum spray reagent:' Solution I: To 100 ml
25N sulphuric acid 4,0 g molybdic acid is added and
the mixture boiled gently until the molybdic acid has
dissolved.
Solution Il: To 50 ml solution I, 0,178 g powdered
molybdenum is added and the mixture boiled gently for
15 min. The solution is allowed to cool and is then
decanted from any residue that may be present.
Molybdenum spray: To 20 ml solution I, 20 ml of
solution II and 80 ml water are added. This spray is
stable for several months at room temperature.
Procedure
A B c o E
s
To :\ ml of uncentrifuged, unfiltered amniotic fluid,
5 ml methanol and 10 ml chloroform are added, and
the resultmg mIxture is mechanically shaken for 5 min.
This mi>.ture is then ct:ntrifuged at 2 200 rpm for 4 min
Fig. 1. Thin-layer chromatogram 01" amniotic fluid samples
I"rom 5 patients. LSAR values are A = 1,6; B = 2,3;
C = 2,1; D = 2,6; and E = 4,7. Sample A was taken at
30 weeks, while samples B to E were taken at term. The
relative increase in the area of lecithin (I) is clearly seen.
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Fig. 2. Graph of LSAR values plotted against weeks of
gestation in the case of fi3 normal patients. Serial tests
on individual patients are joined.
LSAR values above 2,0 and none of these infants devtloped
respiratory distre:;s even though some of them were
premature. Tht; remaining result (0) fell into the inter-
mediate range, having an LSAR of 1,6 at about 38 weeks
(gestatio\-,al age uncertain). A Caesarean section was per-
formed at this stage, and the infant developed respiratory
distress but survived. In the case of the determination
marked H the LSAR value at 34 weeks was 1,3 i.e.
falling into the high-risk group. A Caesarean section was
performed 21 weeks later without requesting a repeat
LSAR determination-the infant developed severe respira-
tory di~tress and died of hyaline membrane disease. The
cause of death was confirmed histologically.
Clinical Interpretation
reported as the 'lecithin: sphingomyelin area ratio' (LSAR).
Screw-type dividers facilitate accurate measurement of the
spots. A few hours after spraying, these blue spots
gradually begin to fade.
The LSAR estimation should not be performed on
amniotic fluid samples contaminated with meconium or
chlorhexidine antiseptic cream, as they have been proved
to yield unreliable results."o Blood-stained f1uids"lD and
fluids contaminated with vaginal secretions should also be
excluded.
The amniotic fluid sample should be assayed as soon
as possible after collection, since an up-to-date LSAR re-sult
is obviously of far greater significance to the obstetrician
than one of a sample taken a few days previously.
Furthermore, there have been conflicting reports published
as to the stability of lecithin in amniotic fluid on storage.n ' l'
Prior to 33 weeks of gestation the normal range of
LSAR values is 0,3 - 2,OY' From the 33rd week onwards
the LSAR begins to rise, corresponding to the increase in
lecithin in the fetal lung. The rate of increase varies
widely among individuals due to the widening of the
normal range on approaching term. By 38 weeks LSAR
values of at least 1,5 should be obtained, rising to
between 2,0 and 9,0 at term."l' Once the LSAR exceeds
2,0 a continued rise can be expected in normal pregnancies.
The LSAR values can be roughly divided into 3
groups:'·"·15
The high-risk group which has values of less than 1,5,
indicating a dangerously immature fetal lung. Delivery at
this time results in the almost invariable development of
severe respiratory distress, often with hyaline membranes,
and death.
The intennediate group with values ranging from 1,5 to
1,9, indicating a transitional lung in which there is some
risk of respiratory distress, but in a milder form than in
the case of the high-risk group.
The nonnal group with ratios of 2,0 or more, indicating
a fully mature fetal lung where respiratory distress will
not occur if the infant is delivered.
Thus it should be possible to eliminate neonatal respira-
tory distress by withholding elective delivery until a
mature lung pattern is present.
DISCUSSION
RESULTS
The LSAR was determined in the case of 85 samples of
amniotic fluid taken from 82 normal subjects. These deter-
minations are shown in Fig. 2. This figure confirms the
expected increase in LSAR values after the 34th week
of gestation. The 3 pairs of points A-B, CoD and E-F are
consecutive tests on 3 subjects. In each of these 3 cases,
the LSAR value was considerably higher in the later
determination.
In the case of 44 of these 85 determination~, delivery
occurred within 72 hours of the amniotic fluid sample
being removed and tested. Of these 44 cases 43 had
Increased-Risk Pregnancies
The LSAR estimation can prove to be an invaluable aid
in the management of increased-risk pregnancies due to
rhesus incompatibility, chronic placental insufficiency,
diabetes, or other high-risk clinical conditions. In severe
cases of rhesus incompatibility the amniotic fluid LSAR and
bilirubin level" will prove a valuable guide to the treatment
of the .patient. If the bilirubin level indicates that the
fetus is in jeopardy, and the LSAR shows a mature
fetal lung, it would be best to deliver the infant
immediately',1.,., rather than favour fetal blood trans-
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fusion which carries a 6,4% risk" of traumatic fetal
death. However, if a low LSAR is obtained, results would·
favour a fetal blood transfusion, thus allowing delivery
to be delayed until the LSAR value is above 2,0, since
much of the perinatal mortality in rhesus incompatibility
is due to the combined effect of severe haemolysis and
respiratory distre~s.
In cases of chronic placental insufficiency an accurate
assessment of the degree of fetal pulmonary maturity
will help in selecting the optimum time for induction of
labour. The correct timing of Caesarean sections or
induction of labour when gestational age is uncertain,
can also be facilitated by up-to-date LSAR results. Un-
complicated Caesarean sections have an 8,6% incidence
of premature infants, and· this figure rises to as much
as 16~o in elective repeat Caesarean sections." A normal
LSAR result indicating a mature fetal lung would allow
a Caesarean section to be performed in the knowledge that
respiratory distress will not occur, even if the infant is
premature. However, in acute complications such as pla-
cental abruption or fulminant pre-eclampsia, immediate
delivery may be essential regardless of the risk of neonatal
respiratory distress.
In pregnancies complicated with maternal diabetes
results tend to indicate that the expected terminal rise in
the LSAR value occasionally fails to occur," or that there
is a retardation of lung maturation.'" In such cases the
current level of the LSAR, and also the trend of the
ratio determined by serial tests, could prove to be a
deciding factor in determining the most suitable time for
the induction of labour. Also, because of the increased
incidence of stillbirths in diabetics after 37 weeks of
gestation, labour could be induced as soon as full pul-
monary maturity is established, thus reducing the risk
involved in the unnecessary continuation of a potentially
lethal intra-uterine state.
Current Methods
Bhagwanani et al.1.1,,. measured the actual lecithin con-
tent of amniotic fluid as an index of fetal pulmonary
maturity. Although more precise than measuring the
lecithin/sphingomyelin area ratio, the method is much
longer and more cumbersome, the modified version" still
requiring 3 hours to perform. In addition, more specialised
equipment is needed. A further disadvantage of this
method, and also of the 'shake' test to be discussed later,
is that results are dependent on the total amniotic fluid
volume. Gadd" and Falconer et al." found that the total
liquor volume increased with gestational age up to 34 - 36
weeks, then reached a plateau, finally falling as term
approached. These workers also found considerable
variations above and below the mean liquor volume which
would alter the lecithin concentration in the liquor in
these cases. This would confuse the issue in a borderline
case, since an accurate result would be dependent on a
normal liquor volume.
On the whole, LSAR and lecithin results have been
found to agree well,"'''''· with lecithin values above 3,5
mg/lOO ml indicating a fully mature fetal lung.
, By far the quickest of the 3 methods currently in use
for estimating fetal lung maturity is the 'shake" test, a
screening test devised by Clements et al."" This test is
based on the ability of the pulmonary surfactant to
generate stable foam in the presence of ethanol. The
sample of amniotic fluid at various dilutions is shaken
and examined for bubbles after 15 minutes. The obvious
advantages of this method are that it is extremely quick
and can be carried out by unskilled persons with a
minimum of apparatus and chemicals, thus cutting down
the cost. However, the proportions in this method are
critical, clean glassware must be used, and care is needed
in the interpretation of results. A clearly negative shake
test at 1/1 dilution indicates a high risk of respiratory
distress, whereas a clearly positive test at 1/2 dilutions
signals a Iow risk."" The shake test can only be regarded
as a semiquantitative test, and has -been reported to give
false positive and false negative results:"·'" In the current
work, LSAR values were determined in the case of 59
patients while tbe surfactant content of the amniotic
fluid taken from these patients was determined simul-
taneously by other workers using the shake test. In 15%
of the results the shake test gave results totally contra-
dictory to those of the LSAR method. The graph in Fig. 3
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Fig. 3. Graph of LSAR values v.shake test values. The
broken lines indicate the respective mature levels. All those
points falling into rectangles A and D are total contra-
dictions.
The LSAR method described, however, is accurate.
quick, and simple to perform in any routine laboratory.
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the entire procedure taking little more than an hour.
Results are not affected by amniotic fluid volume, and the
method does not require elaborate equipment.
The value of the LSAR method would be extended
with the development of more effective methods for the
inhibition of premature labour until the fetal lung is
fully mature. Furthermore, a reliable method to stimulate
production of surfactant pharmacologically would be of
great use. Experimentally, both heroin and steroids have
been administered to pregnant rabbits and sheep or in-
jected directly into the amniotic fluid or fetus to accelerate
the production of surfactant in the fetal lung.""30 Recent-
ly, steroids used in human pregnancy have been reported
to accelerate fetal lung maturity." This is further con-
firmed by the low incidence of respiratory distress syn-
drome in premature infants born to heroin-addicted
mothers.""
APPENDIX
The area of an ellipse is:
II ab .... (1)
where a and b are respectively the semimajor axis and the
semiminor axis of the ellipse.
Since it is easier to measure 2a and 2b in practice, 2a and
2b are substituted in formula (1). The resulting area is then
4 times too large. However, since a ratio is required, the 4 IT
in both the numerator and denominator cancel out, leaving:
(a X b) lecithin (length X width) lecithin
-------- ..• (2)
(a X b) sphingomyelin (length X width) sphingomyelin
~he .above holds true only for perfect ellipses or circles,
whIch IS not always the case in the present work. However
with LSAR values in the range of 2,0 or less, the spots s~
closely resemble ellipses or circles (Fig. 1, A, B, C) that (2)
can be used with a high degree of accuracy.
In general, only for LSAR values well above 2,0 does the
lecithin spot vary considerably in shape from an ellipse (Fig.
I,E) and since all values above 2,0 are classified normal the
inaccuracy in area measurement in this range is not critical.
I should like to thank Drs P. Canham and B. Ramsing of
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